₹ 163.1 Cr
1.18%
NIFTY Pharma TRI
INF109KC18L6
1000.0
1000.0
1000
Nishit Patel, Ashwini Bharucha, Venus Ahuja
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund - Growth | 17.08 | 20.53 | - |
| Nifty Pharma TRI | 18.44 | 22.05 | 14.09 |
Equity
Debt
Others
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 19.5 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 11.97 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 7.82 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 7.68 |
| Dr. Reddys Laboratories Ltd | 7.62 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 7.16 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.0 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.68 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 3.56 |
| ALKEM LABORATORIES LIMITED EQ | 3.16 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.93 |
| Scheme Name | 5Y (%) |
|---|---|
| ICICI Prudential Nifty Pharma Index Fund Gr | 0.0 |